Innovation RVU proposal would give medical invention a place in career evaluation

A new proposal from IO Lab outlines a way for health systems to recognize work involved in developing medical technologies. Published in Nature Biotechnology, the article introduces the innovation relative value unit, or innovation RVU. The framework would assign credit to activities such as securing patents, licensing technology and bringing a company or product through defined milestones.

IO Lab researchers address a gap between the work required to develop an invention and the activities commonly rewarded in academic medicine. A clinician may spend substantial time evaluating a need, working with engineers or helping a technology reach users. The proposal asks how institutions could make those contributions visible in career and compensation decisions.

The framework assigns points to different kinds of innovation activity. Examples include company formation, intellectual property, licensing, regulatory milestones and work with industry. Institutions could adapt the weights to their own goals. The authors also describe ways to account for a project’s reach and the financial resources available in the setting where it develops.

Illustrative examples show how the system might work for different professional profiles. These are hypothetical cases used to explain the proposal. They do not represent measured improvements in innovation output or evidence that a particular scoring system changes clinicians’ behavior.

Putting such a framework into practice would require clear definitions and review. A patent, for example, records an intellectual-property milestone but does not by itself establish clinical benefit. Advisory roles and company registrations can also vary widely in substance. The authors discuss the risk that participants could accumulate points through activities that produce little meaningful progress.

For an institution considering the idea, transparency would be central. Faculty would need to understand which contributions count, how teams share credit and who verifies achievements. A fair process would also need to consider access to funding, mentors and protected time. Those conditions affect a person’s opportunity to participate in technology development.

The article presents a framework for discussion rather than a tested compensation model. Its effects on research quality, career advancement and patient care remain to be evaluated. A pilot could examine whether recognizing innovation changes participation and whether the credited work produces useful results. The proposal gives health systems a concrete starting point for deciding how medical invention should fit alongside clinical care, teaching and research.